TAVI in Intermediate-risk patients: a review in purpose of a case

TAVI in Intermediate-risk patients: a review in purpose of a case

Abstract: Background: Aortic stenosis is the most common valvular heart disease worldwide. The prognosis is adverse without a valve replacement. Transcatheter aortic valve implantation (TAVI) has proven to be an effective treatment in high-surgical risk patients. Recent trials have highlighted the non-inferiority of TAVI compared with open surgery in patients with intermediate surgical risk. Case report: A 76-year-old man with severe aortic stenosis and intermediate surgical risk (STS-PROM 4.8%) who underwent TAVI with no complications. Results: Hospital discharge was decided five days after the procedure and continued outpatient follow-up. After two years remains in NYHA functional class I with a normofunctional percutaneous prosthesis. Conclusion: As this clinical case shows, TAVI has proven to be an effective treatment in patients with aortic stenosis and intermediate surgical risk. This is the first experience in this type of patients reported in our country.

Saved in:
Bibliographic Details
Main Authors: Escutia-Cuevas,Héctor Hugo, Merino-Rajme,José Alfredo, Alcántara-Meléndez,Marco Antonio, Espinoza-Rueda,Manuel Armando, Fernández-Ceseña,Ernesto, García-García,Juan Francisco, Morales-Portano,Julieta Danira, Muratalla-González,Roberto, Ordoñez-Salazar,Bayardo Antonio
Format: Digital revista
Language:English
Published: Asociación Nacional de Cardiólogos de México, Sociedad de Cardiología Intervencionista de México 2018
Online Access:http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0188-21982018000200102
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract: Background: Aortic stenosis is the most common valvular heart disease worldwide. The prognosis is adverse without a valve replacement. Transcatheter aortic valve implantation (TAVI) has proven to be an effective treatment in high-surgical risk patients. Recent trials have highlighted the non-inferiority of TAVI compared with open surgery in patients with intermediate surgical risk. Case report: A 76-year-old man with severe aortic stenosis and intermediate surgical risk (STS-PROM 4.8%) who underwent TAVI with no complications. Results: Hospital discharge was decided five days after the procedure and continued outpatient follow-up. After two years remains in NYHA functional class I with a normofunctional percutaneous prosthesis. Conclusion: As this clinical case shows, TAVI has proven to be an effective treatment in patients with aortic stenosis and intermediate surgical risk. This is the first experience in this type of patients reported in our country.

Similar Items